Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Syntheses and in silico pharmacokinetic predictions of glycosylhydrazinyl-pyrazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]triazolo[4,3-a]pyrimidines as anti-proliferative agents

Journal Article · · Medicinal Chemistry Research (Print)
;  [1];  [2];  [1];  [3]
  1. Alexandria University, Chemistry Department, Faculty of Science (Egypt)
  2. The Ministry of Education (Yemen)
  3. Kafrelsheikh University, Pharmaceutical Chemistry Department, Faculty of Pharmacy (Egypt)
New glycosylhydrazinyl-pyrazolo[1,5-c]pyrimidines were synthesized by the reaction of respective 5-aryl-7-hydrazino-2-phenylpyrazolo[1,5-c]pyrimidines (1a-d) with glucose, galactose, and xylose in ethanol. Their glycopyranosyl structures were reasoned to be in chair conformations and each have hydrazine moiety in the β-configuration. Also, pyrazolo[1,5-c]triazolo[4,3-a]pyrimidines derivatives were synthesized by the reaction of 1a-d with benzoic acid in the presence of phosphorousoxy chloride or by the reaction with benzaldehyde derivatives followed by cyclization in the presence of bromine. All structures of the compounds were confirmed from their IR, {sup 1}H, {sup 13}C, DPET-135°, {sup 1}H-{sup 1}H COSY, {sup 1}H-{sup 13}C HMQC, {sup 13}C-{sup 1}H HMBC spectra and microanalysis. The synthesized compounds showed inhibition of proliferation of MCF-7 human breast cancer cells with IC{sub 50} values ranging from 0.56 to 8.86 µg/ml. Some of the most active compounds showed acceptable predicted pharmacokinetics and drug-likeness properties. .
OSTI ID:
22936212
Journal Information:
Medicinal Chemistry Research (Print), Journal Name: Medicinal Chemistry Research (Print) Journal Issue: 2 Vol. 28; ISSN 1054-2523
Country of Publication:
United States
Language:
English

Similar Records

Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
Journal Article · Mon Jun 30 00:00:00 EDT 2008 · Bioorg. Med. Chem. Lett. · OSTI ID:1007629

Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 2
Journal Article · Tue Nov 19 23:00:00 EST 2013 · Bioorg. Med. Chem. Lett. · OSTI ID:1025622

Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach
Journal Article · Fri Nov 01 00:00:00 EDT 2013 · Bioorganic and Medicinal Chemistry Letters · OSTI ID:1404959